Dermatology and Venereology (Lund)
21 – 30 of 644
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Results of a non-randomized, open-label phase I study evaluating the novel Immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa
(2025) In Orphanet Journal of Rare Diseases
- Contribution to journal › Article
-
Mark
Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma : A Nationwide Population-Based Registry Study from Sweden
(2025) In The British journal of dermatology
- Contribution to journal › Article
-
Mark
Recovery from severe MDA5-associated dermatomyositis with only limited immunosuppression
- Contribution to journal › Letter
-
Mark
Response to Birrell SN : Commentary on “Photosensitizing Drugs and Risk of Skin Cancer in Women”
- Contribution to journal › Letter
-
Mark
Addressing infection in totally implantable venous access ports : An ex vivo study on bacterial transfer and the Forsvall Port needle design
(2025) In Journal of Vascular Access
- Contribution to journal › Article
-
Mark
Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study
- Contribution to journal › Article
-
Mark
Surgical attire in Mohs micrographic surgery—A survey study
(2025) In Journal of the European Academy of Dermatology and Venereology
- Contribution to journal › Letter
-
Mark
Antihypertensive Medication as a Risk Factor For Basal Cell Carcinoma : A Nationwide Registry-based Case-control Study
- Contribution to journal › Article
-
Mark
Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden : An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative
(2025) In Dermatology
- Contribution to journal › Article
-
Mark
Editorial : Advancements in translational models: bridging basic infection research and clinical applications
- Contribution to journal › Debate/Note/Editorial
